[
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Ascends But Remains Behind Market: Some Facts to Note",
    "summary": "In the most recent trading session, Gilead Sciences (GILD) closed at $111.88, indicating a +0.54% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=cf659bc1666231ed0832c3d3039c5c2e5cf9c139c75e426d63d85f61e7d28d3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743631216,
      "headline": "Gilead Sciences (GILD) Ascends But Remains Behind Market: Some Facts to Note",
      "id": 133695094,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Gilead Sciences (GILD) closed at $111.88, indicating a +0.54% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=cf659bc1666231ed0832c3d3039c5c2e5cf9c139c75e426d63d85f61e7d28d3e"
    }
  },
  {
    "ts": null,
    "headline": "Arcus Biosciences: A High-Risk Speculation With Multiple Large, Near-Term Catalysts",
    "summary": "Arcus Biosciences is a high-risk speculation with major upcoming catalysts, despite stock declines and Gilead's exit from the ARC-10 trial. Read more about RCUS stock here.",
    "url": "https://finnhub.io/api/news?id=7ff22a089fc138e5532998c8cbba75b7b9579cb68817a0be17087dea945aded1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743608933,
      "headline": "Arcus Biosciences: A High-Risk Speculation With Multiple Large, Near-Term Catalysts",
      "id": 133675042,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2098875652/image_2098875652.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Arcus Biosciences is a high-risk speculation with major upcoming catalysts, despite stock declines and Gilead's exit from the ARC-10 trial. Read more about RCUS stock here.",
      "url": "https://finnhub.io/api/news?id=7ff22a089fc138e5532998c8cbba75b7b9579cb68817a0be17087dea945aded1"
    }
  },
  {
    "ts": null,
    "headline": "Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=8d2f7e145148026532985f94ad3428fa05959cf68ff0857b4f80e88ea8ad6e26",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743601208,
      "headline": "Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term",
      "id": 133669564,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=8d2f7e145148026532985f94ad3428fa05959cf68ff0857b4f80e88ea8ad6e26"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=166d21d6701f7e76d706e8da9ba4cf3f0129558ed66ca7da3f69c2d91a3a13b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743598810,
      "headline": "Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know",
      "id": 133669565,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=166d21d6701f7e76d706e8da9ba4cf3f0129558ed66ca7da3f69c2d91a3a13b3"
    }
  }
]